Top Markets
Coin of the day
Orum Therapeutics, Inc. Orum Therapeutics, Inc.

Orum Therapeutics, Inc.

475830
Clasificación en acciones #9664
Orum Therapeutics, Inc. is a biopharmaceutical company dedicated to the... Orum Therapeutics, Inc. is a biopharmaceutical company dedicated to the discovery and development of novel therapeutic solutions for both cancer and immune system conditions. The firm specializes in creating degrader-antibody conjugates, an innovative class of drugs that merges traditional antibody-drug conjugate (ADC) technology with targeted protein degradation. Their flagship product candidate, ORM-1153, functions as a GSPT1 protein degrader, specifically engineered to address hematologic malignancies. Orum Therapeutics was established in 2016 and operates out of Daejeon, South Korea.
Precio por acción
$45.64
Última sincronización: 2026-08-28
Capitalización bursátil
$969.02M
Cambio (1 día)
-1.20%
Cambio (1 año)
146.66%
País
KR
Comercio Orum Therapeutics, Inc. (475830)

Categoría

Ratio P/B de Orum Therapeutics, Inc. (475830)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Orum Therapeutics, Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Orum Therapeutics, Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
3.7087 -
US
- -
CH